Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 04 04:00PM ET
1.56
Dollar change
+0.01
Percentage change
0.65
%
IndexRUT P/E- EPS (ttm)-2.98 Insider Own34.91% Shs Outstand52.74M Perf Week4.70%
Market Cap82.28M Forward P/E- EPS next Y-2.50 Insider Trans-0.10% Shs Float34.33M Perf Month4.70%
Income-151.16M PEG- EPS next Q-0.67 Inst Own58.48% Short Float21.05% Perf Quarter-21.61%
Sales0.00M P/S- EPS this Y26.31% Inst Trans-9.46% Short Ratio10.27 Perf Half Y-82.27%
Book/sh2.59 P/B0.60 EPS next Y9.14% ROA-74.50% Short Interest7.23M Perf Year-81.20%
Cash/sh2.82 P/C0.55 EPS next 5Y- ROE-98.94% 52W Range1.19 - 17.83 Perf YTD-89.52%
Dividend Est.- P/FCF- EPS past 5Y-50.98% ROI-99.25% 52W High-91.25% Beta1.04
Dividend TTM- Quick Ratio4.82 Sales past 5Y-8.67% Gross Margin- 52W Low31.09% ATR (14)0.14
Dividend Ex-Date- Current Ratio4.82 EPS Y/Y TTM16.43% Oper. Margin- RSI (14)55.14 Volatility10.97% 8.89%
Employees72 Debt/Eq0.13 Sales Y/Y TTM- Profit Margin- Recom1.57 Target Price10.40
Option/ShortYes / Yes LT Debt/Eq0.11 EPS Q/Q52.98% Payout- Rel Volume1.70 Prev Close1.55
Sales Surprise- EPS Surprise25.64% Sales Q/Q- EarningsNov 07 AMC Avg Volume703.59K Price1.56
SMA2010.05% SMA502.46% SMA200-78.42% Trades Volume1,192,023 Change0.65%
Date Action Analyst Rating Change Price Target Change
Mar-08-24Downgrade Stifel Buy → Hold $10 → $14
Dec-08-23Upgrade Jefferies Hold → Buy $8 → $18
Dec-22-21Downgrade Jefferies Buy → Hold $65 → $25
Sep-30-21Initiated Stifel Buy $106
May-05-21Resumed Credit Suisse Outperform $98
Apr-26-21Resumed Credit Suisse Outperform $98
Apr-06-21Initiated UBS Buy
Feb-10-21Initiated H.C. Wainwright Buy $100
Aug-11-20Initiated Piper Sandler Overweight $55
Aug-11-20Initiated Jefferies Buy $50
Nov-26-24 08:00AM
Nov-21-24 09:35AM
Nov-14-24 08:00AM
Nov-07-24 04:00PM
Nov-04-24 08:00AM
05:30PM Loading…
Nov-01-24 05:30PM
Oct-10-24 07:04PM
Sep-09-24 08:00AM
Sep-04-24 08:00AM
Aug-08-24 04:05PM
Aug-06-24 04:01PM
Aug-01-24 09:05AM
06:52AM
Jul-31-24 04:01PM
05:30AM
11:00AM Loading…
Jun-17-24 11:00AM
Jun-03-24 09:35AM
Jun-02-24 10:00AM
May-29-24 09:00AM
May-16-24 02:54AM
May-14-24 09:55AM
May-10-24 02:21PM
May-09-24 10:57PM
04:00PM
May-08-24 05:38PM
May-07-24 09:00AM
Apr-30-24 09:00AM
Apr-24-24 10:00AM
Apr-11-24 09:30AM
Apr-09-24 05:30PM
01:33AM Loading…
Apr-06-24 01:33AM
Mar-08-24 03:48PM
Mar-07-24 10:53PM
10:41PM
04:03PM
Mar-05-24 04:30PM
Jan-03-24 08:00AM
Dec-22-23 04:21PM
Nov-13-23 04:47PM
04:05PM
Nov-01-23 04:05PM
Oct-10-23 04:05PM
Oct-06-23 04:59AM
Oct-05-23 10:58AM
08:00AM
Oct-04-23 04:10PM
11:39AM
Oct-03-23 11:15AM
09:36AM
06:00AM
Oct-02-23 04:05PM
Sep-06-23 08:00AM
Aug-31-23 07:00AM
Aug-14-23 07:31PM
Aug-10-23 04:01PM
09:55AM
Jun-26-23 07:00AM
May-11-23 04:01PM
May-09-23 07:00AM
Apr-25-23 07:00AM
Apr-19-23 11:36AM
Mar-14-23 08:00AM
Mar-13-23 07:00AM
Mar-09-23 04:01PM
Feb-16-23 07:00AM
Jan-05-23 07:00AM
Jan-03-23 07:00AM
Dec-12-22 10:00AM
Nov-29-22 07:00AM
Nov-08-22 04:01PM
Nov-03-22 09:00AM
Nov-02-22 07:00AM
Oct-31-22 07:00AM
Oct-05-22 08:01AM
Sep-21-22 04:01PM
Sep-01-22 07:00AM
Aug-16-22 09:45AM
Aug-15-22 07:00AM
Aug-11-22 07:00AM
Aug-08-22 04:01PM
Aug-01-22 07:00AM
Jun-29-22 08:44AM
07:00AM
Jun-22-22 09:00AM
Jun-03-22 07:00AM
Jun-01-22 07:00AM
Apr-12-22 07:00AM
Mar-02-22 07:00AM
Feb-28-22 07:00AM
Feb-03-22 07:01PM
Feb-02-22 01:38PM
Jan-28-22 12:44PM
08:02AM
Jan-27-22 05:51PM
Jan-19-22 06:23AM
Jan-10-22 06:00AM
Jan-04-22 07:00AM
Dec-14-21 09:00AM
Dec-13-21 01:58PM
Dec-12-21 09:00AM
ALX Oncology Holdings, Inc. operates as a clinical stage company, which engages in the research and development of therapies for cancer patients. Its objective is to provide clinical therapies for the treatment of myelodysplastic syndromes, acute myeloid leukemia, and a range of solid tumor indications. The company was founded by Corey Goodman, Jaume Pons, and K. Christopher Garcia in March 2015 and is headquartered in South San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hemrajani RekhaDirectorDec 02 '24Buy1.5530,00046,40433,000Dec 04 04:17 PM
Pinto ShellySVP, FINANCE AND CAOAug 14 '24Sale2.585641,45591,549Aug 16 05:10 PM
Randolph SophiaCHIEF MEDICAL OFFICERAug 14 '24Sale2.581,3653,522325,711Aug 16 05:09 PM
Pons JaumePRESIDENT & CSOAug 14 '24Sale2.581,9374,997591,510Aug 16 05:06 PM
Pons JaumePRESIDENT & CSOJul 11 '24Option Exercise0.9920,00019,800613,447Jul 15 04:06 PM
Pons JaumePRESIDENT & CSOJul 11 '24Sale7.9020,000158,076593,447Jul 15 04:06 PM
Pinto ShellySVP, FINANCE AND CAOJul 05 '24Sale5.501,82310,02592,113Jul 09 04:09 PM
Pinto ShellySVP, FINANCE AND CAOJul 01 '24Sale5.821,3737,98993,936Jul 03 05:03 PM
Randolph SophiaCHIEF MEDICAL OFFICERJul 01 '24Sale5.823,27319,045327,076Jul 03 05:02 PM
Pons JaumePRESIDENT & CSOJul 01 '24Sale5.8210,75862,599593,447Jul 03 05:00 PM
GARCIA PETER SCHIEF FINANCIAL OFFICERJun 13 '24Buy8.5312,000102,338122,348Jun 17 07:29 AM
Pons JaumePRESIDENT & CSOJun 04 '24Option Exercise0.9920,00019,800624,205Jun 06 04:06 PM
Pons JaumePRESIDENT & CSOJun 04 '24Sale8.4320,000168,652604,205Jun 06 04:06 PM
Randolph SophiaCHIEF MEDICAL OFFICERMay 13 '24Sale15.9412,000191,339330,349May 15 04:30 PM
Pons JaumePRESIDENT & CSOMay 06 '24Option Exercise0.9920,00019,800624,205May 08 05:31 PM
Pons JaumePRESIDENT & CSOMay 06 '24Sale15.9220,000318,334604,205May 08 05:31 PM
Pons JaumePRESIDENT & CSOApr 16 '24Option Exercise0.9925,84625,588654,205Apr 18 04:49 PM
Pons JaumePRESIDENT & CSOApr 16 '24Sale14.2050,000710,195604,205Apr 18 04:49 PM
Pons JaumePRESIDENT & CSOApr 04 '24Sale11.1520,000223,036628,359Apr 05 05:37 PM
Lettmann JasonCHIEF EXECUTIVE OFFICERMar 14 '24Buy11.314,40049,771171,620Mar 18 04:06 PM
Pinto ShellySVP, Finance and CAOJan 04 '24Sale13.602,71736,95778,591Jan 05 04:03 PM
Pinto ShellySVP, Finance and CAODec 29 '23Sale15.041,63124,53081,308Jan 03 04:28 PM
Randolph SophiaChief Medical OfficerDec 29 '23Sale15.043,12847,045312,349Jan 03 04:25 PM
GARCIA PETER SChief Financial OfficerDec 29 '23Sale15.041,89328,47185,348Jan 03 04:20 PM
Pons JaumePresident & CSODec 29 '23Sale15.047,179107,972618,359Jan 03 04:17 PM